scPharmaceuticals Inc. (SCPH) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 73 transactions totaling $78.8M, demonstrating a bullish sentiment with $66.8M in net insider flow. The most recent transaction on Oct 7, 2025 involved a transaction of 5,000 shares valued at $0.
No significant insider buying has been recorded for SCPH in the recent period.
No significant insider selling has been recorded for SCPH in the recent period.
Based on recent SEC filings, insider sentiment for SCPH is bullish with an Insider Alignment Score of 92/100 and a net flow of $66.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at scPharmaceuticals Inc. (SCPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading SCPH stock, having executed 73 transactions in the past 90 days. The most active insider is Advisors Llc Orbimed (Executive), who has made 5 transactions totaling $27.7M.
Get notified when executives and directors at SCPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | A. Khattar Jack | Executive | Tender | 5,000 | $N/A | $0 | |
| Oct 7, 2025 | H. Tucker John | Executive | Disposition | 318,502 | $N/A | $0 | |
| Oct 7, 2025 | H. Tucker John | Executive | Tender | 122,345 | $N/A | $0 | |
| Oct 7, 2025 | Nokes Rachael | Executive | Tender | 30,386 | $N/A | $0 | |
| Oct 7, 2025 | Nokes Rachael | Executive | Disposition | 125,675 | $N/A | $0 | |
| Oct 7, 2025 | D. Schaeffer Leonard | Executive | Tender | 68,796 | $N/A | $0 | |
| Oct 7, 2025 | D. Schaeffer Leonard | Executive | Tender | 43,104 | $N/A | $0 | |
| Aug 26, 2024 | D. Schaeffer Leonard | Executive | Option Exercise | 6,124 | $3.37 | $20.6K | |
| Aug 26, 2024 | D. Schaeffer Leonard | Executive | Option Exercise | 5,223 | $1.66 | $8.7K | |
| Aug 13, 2024 | Gp VI Llc Orbimed Capital | Executive | Purchase | 478,342 | $4.00 | $1.9M | Large |
| Aug 13, 2024 | Gp VI Llc Orbimed Capital | Executive | Purchase | 21,658 | $4.00 | $86.6K | |
| Aug 6, 2024 | Nokes Rachael | Executive | Option Exercise | 10,445 | $N/A | $0 | |
| Aug 6, 2024 | Nokes Rachael | Executive | Option Exercise | 10,445 | $1.66 | $17.3K | |
| Jan 18, 2024 | H. Tucker John | Executive | Award | 113,560 | $N/A | $0 | |
| Jan 18, 2024 | Nokes Rachael | Executive | Award | 41,840 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $72.8M | 91.5% |
Sale(S) | 17 | $6.0M | 7.5% |
Award(A) | 4 | $481.2K | 0.6% |
Payment(F) | 6 | $199.4K | 0.3% |
Exercise(M) | 7 | $84.2K | 0.1% |
Tender(U) | 5 | $0 | 0.0% |
Disposition(D) | 2 | $0 | 0.0% |
Conversion(C) | 14 | $0 | 0.0% |
Insiders at scPharmaceuticals Inc. are accumulating shares at an accelerated pace. With 18 insiders making 73 transactions totaling $72.8M in purchases versus $6.0M in sales, the net buying activity of $66.8M signals strong executive confidence. Advisors Llc Orbimed (Executive) leads the buying activity with $27.7M in transactions across all time.